🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/10/2016 6,51 6,59 6,30 6,33 -3,51% 4,45% 388.700
24/10/2016 6,72 6,76 6,52 6,56 -2,09% 3,56% 363.300
21/10/2016 6,76 6,86 6,68 6,70 -1,90% 2,66% 324.900
20/10/2016 6,60 6,85 6,60 6,83 +2,71% 3,79% 617.500
19/10/2016 6,64 6,73 6,52 6,65 +0,00% 3,16% 383.000
18/10/2016 6,68 6,72 6,59 6,65 +0,91% 1,95% 364.700
17/10/2016 6,61 6,69 6,43 6,59 -0,75% 3,93% 510.200
14/10/2016 6,97 6,99 6,64 6,64 -4,46% 5,02% 691.600
13/10/2016 6,76 7,09 6,75 6,95 +1,91% 5,03% 673.000
12/10/2016 6,91 7,10 6,81 6,82 -1,87% 4,20% 573.800
11/10/2016 7,16 7,22 6,87 6,95 -4,01% 4,89% 664.600
10/10/2016 7,20 7,28 7,10 7,24 +2,84% 2,50% 632.600
07/10/2016 7,02 7,10 6,80 7,04 +0,14% 4,22% 964.100
06/10/2016 7,45 7,48 6,95 7,03 -6,52% 7,10% 1.557.600
05/10/2016 7,34 7,74 7,25 7,52 +3,16% 6,68% 930.200
04/10/2016 7,20 7,40 7,10 7,29 +1,53% 4,24% 765.700
03/10/2016 7,47 7,49 7,12 7,18 -2,31% 4,95% 1.007.300
30/09/2016 7,57 7,72 7,25 7,35 +0,68% 6,21% 1.762.700
29/09/2016 8,05 8,09 7,20 7,30 +3,69% 11,06% 6.609.200
28/09/2016 7,13 7,20 6,83 7,04 -1,26% 5,19% 667.000
27/09/2016 7,07 7,24 7,01 7,13 +1,28% 3,27% 450.900
26/09/2016 7,15 7,22 7,03 7,04 -2,49% 2,66% 432.900
23/09/2016 7,27 7,36 7,16 7,22 -0,69% 2,75% 363.500
22/09/2016 7,29 7,34 7,04 7,27 +0,83% 4,06% 567.000
21/09/2016 7,36 7,48 6,98 7,21 -2,04% 6,79% 800.800
20/09/2016 7,19 7,59 7,16 7,36 +3,95% 5,98% 770.600
19/09/2016 7,10 7,25 7,03 7,08 +0,00% 3,10% 503.500
16/09/2016 7,11 7,27 7,02 7,08 -0,84% 3,52% 1.467.100
15/09/2016 6,97 7,24 6,93 7,14 +1,13% 4,45% 566.000
14/09/2016 6,92 7,22 6,89 7,06 +1,73% 4,77% 605.100